CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,648,268 shares; 2025Q1: 7,648,268 shares; 2025Q2: 7,648,268 shares; 2025Q3: 7,648,268 shares; 2025Q4: 7,648,268 shares; 2026Q1: 7,648,268 shares; 2026Q2: 9,731,341 shares; 2026Q3: 9,721,081 shares 9,721,081 $149M 11.49% -10,260 Timeline AKTS AKTIS ONCOLOGY INC More: the full row for AKTIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,835,872 shares; 2026Q2: 4,835,872 shares; 2026Q3: 4,835,872 shares 4,835,872 $94.2M 7.25% 0 Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,133,365 shares; 2026Q2: 1,122,731 shares; 2026Q3: 1,088,363 shares 1,088,363 $64.1M 4.93% -34,368 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,079,316 shares; 2025Q1: 1,105,444 shares; 2025Q2: 1,720,741 shares; 2025Q3: 1,720,741 shares; 2025Q4: 1,655,256 shares; 2026Q1: 1,660,696 shares; 2026Q2: 1,620,780 shares; 2026Q3: 1,575,987 shares 1,575,987 $64M 4.93% -44,793 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,446,361 shares; 2025Q3: 1,446,361 shares; 2025Q4: 1,405,388 shares; 2026Q1: 1,408,152 shares; 2026Q2: 1,922,093 shares; 2026Q3: 3,208,146 shares 3,208,146 $51.7M 3.98% +1,286,053 Timeline CORT CORCEPT THERAPEUTICS INC More: the full row for CORCEPT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 985,700 shares; 2026Q2: 771,028 shares; 2026Q3: 422,000 shares 422,000 $48.6M 3.74% -349,028 Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,268,825 shares; 2025Q1: 2,295,924 shares; 2025Q2: 2,282,680 shares; 2025Q3: 2,282,680 shares; 2025Q4: 2,232,451 shares; 2026Q1: 2,359,586 shares; 2026Q2: 2,415,672 shares; 2026Q3: 2,369,578 shares 2,369,578 $42.8M 3.29% -46,094 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,094,896 shares; 2025Q1: 3,428,366 shares; 2025Q2: 3,406,955 shares; 2025Q3: 3,406,955 shares; 2025Q4: 3,287,087 shares; 2026Q1: 3,298,430 shares; 2026Q2: 3,073,577 shares; 2026Q3: 2,978,906 shares 2,978,906 $42.7M 3.28% -94,671 Timeline IOVA IOVANCE BIOTHERAPEUTICS INC More: the full row for IOVANCE BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,673,905 shares; 2025Q1: 2,708,582 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,835,734 shares 2,835,734 $42M 3.24% new Timeline LQDA LIQUIDIA CORPORATION More: the full row for LIQUIDIA CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 1,400,869 shares; 2026Q1: 1,405,158 shares; 2026Q2: 1,386,174 shares; 2026Q3: 1,342,713 shares 1,342,713 $40.6M 3.13% -43,461 Timeline NTRA NATERA INC More: the full row for NATERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 160,626 shares; 2025Q1: 157,047 shares; 2025Q2: 98,924 shares; 2025Q3: 98,924 shares; 2025Q4: 93,551 shares; 2026Q1: 93,074 shares; 2026Q2: 92,638 shares; 2026Q3: 90,585 shares 90,585 $37.4M 2.88% -2,053 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 135,000 shares; 2025Q4: 941,378 shares; 2026Q1: 943,803 shares; 2026Q2: 933,415 shares; 2026Q3: 909,691 shares 909,691 $37M 2.85% -23,724 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,203,289 shares 1,203,289 $36.4M 2.81% new Timeline DBVT DBV TECHNOLOGIES S A More: the full row for DBV TECHNOLOGIES S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,054,504 shares; 2025Q3: 1,054,504 shares; 2025Q4: 996,825 shares; 2026Q1: 5,213,361 shares; 2026Q2: 3,666,284 shares; 2026Q3: 3,044,659 shares 3,044,659 $35.8M 2.76% -621,625 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,953,562 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,500,000 shares; 2026Q3: 7,262,959 shares 7,262,959 $35.4M 2.72% +2,762,959 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 56,316 shares; 2026Q1: 107,268 shares; 2026Q2: 336,347 shares; 2026Q3: 328,379 shares 328,379 $32.5M 2.5% -7,968 Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,809,711 shares 2,809,711 $31.4M 2.42% new Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,936,291 shares; 2026Q3: 1,956,618 shares 1,956,618 $31.3M 2.41% +20,327 Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,851,604 shares 3,851,604 $31M 2.39% new Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,381,628 shares; 2026Q1: 1,369,231 shares; 2026Q2: 1,225,855 shares; 2026Q3: 1,201,413 shares 1,201,413 $29M 2.23% -24,442 Timeline ODTX ODYSSEY THERAPEUTICS INC More: the full row for ODYSSEY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,289,091 shares 1,289,091 $28.6M 2.2% new Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 341,496 shares; 2025Q3: 341,496 shares; 2025Q4: 328,869 shares; 2026Q1: 329,750 shares; 2026Q2: 322,007 shares; 2026Q3: 352,676 shares 352,676 $27.7M 2.13% +30,669 Timeline PVLA PALVELLA THERAPEUTICS INC NE More: the full row for PALVELLA THERAPEUTICS INC NE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 67,423 shares; 2025Q4: 205,745 shares; 2026Q1: 206,404 shares; 2026Q2: 204,027 shares; 2026Q3: 197,633 shares 197,633 $27.3M 2.1% -6,394 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 391,918 shares; 2026Q2: 1,042,467 shares; 2026Q3: 5,178,127 shares 5,178,127 $27.2M 2.1% +4,135,660 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $25M 1.92% new Timeline ORIC ORIC PHARMACEUTICALS INC More: the full row for ORIC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,399,514 shares; 2025Q2: 1,729,378 shares; 2025Q3: 1,729,378 shares; 2025Q4: 1,798,717 shares; 2026Q1: 1,803,945 shares; 2026Q2: 1,882,162 shares; 2026Q3: 1,821,951 shares 1,821,951 $24.5M 1.89% -60,211 Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 685,826 shares; 2025Q1: 693,988 shares; 2025Q2: 789,698 shares; 2025Q3: 789,698 shares; 2025Q4: 770,289 shares; 2026Q1: 767,038 shares; 2026Q2: 723,314 shares; 2026Q3: 925,133 shares 925,133 $24.1M 1.85% +201,819 Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 87,760 shares; 2026Q1: 88,045 shares; 2026Q2: 137,208 shares; 2026Q3: 133,387 shares 133,387 $22.7M 1.74% -3,821 Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 771,839 shares 771,839 $21.5M 1.65% new Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,472,843 shares; 2026Q3: 4,449,671 shares 4,449,671 $18.5M 1.42% -23,172 Timeline ANNX ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,544,354 shares; 2026Q3: 4,290,616 shares 4,290,616 $18.1M 1.4% +746,262 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,173,376 shares; 2026Q1: 1,176,928 shares; 2026Q2: 1,161,081 shares; 2026Q3: 1,125,216 shares 1,125,216 $13.4M 1.03% -35,865 Timeline BIOA BIOAGE LABS INC More: the full row for BIOAGE LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,667,661 shares; 2026Q3: 1,856,748 shares 1,856,748 $13.2M 1.01% +189,087 Timeline CRBP CORBUS PHARMACEUTICALS HLDGS More: the full row for CORBUS PHARMACEUTICALS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,667,272 shares 1,667,272 $11.4M 0.88% new Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 230,147 shares; 2026Q1: 212,175 shares; 2026Q2: 202,114 shares; 2026Q3: 195,669 shares 195,669 $9.75M 0.75% -6,445 Timeline TRAX FIRST TRACKS BIOTHERAPEUTICS More: the full row for FIRST TRACKS BIOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 254,374 shares 254,374 $9.02M 0.69% new Timeline